As one of the leading medical products companies, Singclean was invited to attend the 2019 annual medical device industry standard development and revision kick-off meeting held in Tianjin on 20, March to complete three verification schemes (half of the total) for revisions of standards for cross-linked sodium hyaluronate gel for plastic surgery.
Considering the revisions will speed up the development of the healthcare industry, Singclean puts the work in the first place and proposes the new schemes in a short time.
•All the schemes adopted are as follows:
Method for determining free sodium hyaluronate content
Method for determining swelling degree of cross-linked sodium hyaluronate gel
Method for determining cross-linked sodium hyaluronate gel protein content
-
singclean | 2019-05-24Headlining FIGO 2025: A Can’t-Miss Keynote by Prof. Osama Shawki, Presented by Singclean & KSMSingclean, in partnership with Kayan Al-Seha Medical (KSM), will debut at FIGO 2025 in Cape Town with a keynote lecture by renowned gynecologist Professor Osama Shawki. His session will spotlight innovations in hysteroscopy and adhesion prevention, showcasing Singclean’s commitment to advancing women’s healthcare worldwide.
-
singclean | 2019-05-24Singclean Draws Major Attention at ESCRS 2025 with Advanced Viscoelastic Solution for Ophthalmic SurgeryCOPENHAGEN, DENMARK – Hangzhou Singclean Medical Products Co., Ltd. made a strong impression at the 45th ESCRS Congress (European Society of Cataract and Refractive Surgeons), held September 12–16, 2025, at the Bella Center in Copenhagen. Recognized globally for its high professional standards and influence in ophthalmology, the congress gathered leading industry manufacturers, surgeons, and specialists from around the world.
-
singclean | 2019-05-24Singderm Filler Achieves 92.7% Efficacy at 12 Months in Global Clinical Trial, Validated by Landmark Thailand MasterclassBangkok, Thailand – Singderm, a globally certified dermal filler brand, has demonstrated unprecedented clinical performance in its Thailand Masterclass led by renowned physician Dr. Worawat Nolah. Three top KOLs (Hack Anantaya, Chalidaorn PinNy, Thantaya Thuranuch) received multi-zone injections with zero complications, reinforcing Singderm’s 92.7% 12-month efficacy rate from a 100-subject clinical trial.